ICD10 code of Lennox-Gastaut syndrome and ICD9 code

The ICD-10-CM code for Lennox-Gastaut syndrome is G40.82 (Lennox-Gastaut syndrome), and the corresponding ICD-9-CM code is 345.40. These diagnostic codes are essential for medical billing, insurance authorization, and identifying the condition in clinical records for patients navigating the complexities of this rare epilepsy.

What is Lennox-Gastaut syndrome?

Lennox-Gastaut syndrome is a severe form of childhood-onset epilepsy characterized by multiple types of drug-resistant seizures, cognitive impairment, and a specific "slow spike-and-wave" pattern on an electroencephalogram (EEG). Typically emerging between the ages of 3 and 5, Lennox-Gastaut syndrome represents a challenging diagnosis for families, often requiring a multidisciplinary care team. Within the DiseaseMaps.org community, 105 people with Lennox-Gastaut syndrome have connected to share their experiences and navigate the daily realities of managing this chronic condition.

How is Lennox-Gastaut syndrome classified?

In medical coding, accurate classification is vital for accessing specialized therapies. The ICD-10-CM code G40.82 is specific to Lennox-Gastaut syndrome and distinguishes it from other epileptic encephalopathies. Previously, the ICD-9-CM code 345.40 was used to classify "localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with complex partial seizures," which historically encompassed the clinical presentation of Lennox-Gastaut syndrome. These codes help clinicians track the prevalence and treatment outcomes of Lennox-Gastaut syndrome across global healthcare systems.

What are the clinical requirements for a diagnosis?

A diagnosis of Lennox-Gastaut syndrome is typically established by a pediatric neurologist through a combination of clinical observation and diagnostic testing. Because there is no single genetic test to confirm the syndrome, doctors look for a specific diagnostic triad:

• Multiple seizure types: Most commonly tonic (stiffening), atonic (drop attacks), and atypical absence seizures.


• EEG findings: The hallmark "slow spike-and-wave" pattern (less than 2.5 Hz) during non-REM sleep.


• Cognitive and developmental impact: Varying degrees of intellectual disability or developmental delay that often coincide with the onset of seizures.

How does the syndrome affect daily life?

Living with Lennox-Gastaut syndrome involves significant emotional and practical adjustments for families. Because the seizures are often refractory to standard anti-seizure medications, caregivers frequently explore alternative treatments such as the ketogenic diet, vagus nerve stimulation (VNS), or corpus callosotomy. From a psychological perspective, the unpredictability of seizures can create chronic stress and isolation. Connecting with others through platforms like DiseaseMaps.org allows families to share strategies for managing behavioral challenges and navigating long-term care planning.

Next steps

• Consult a board-certified pediatric epileptologist to ensure your treatment plan is optimized for the latest research.


• Maintain a detailed seizure diary to track frequency and triggers, which is crucial for adjusting medications coded under G40.82.


• Join the DiseaseMaps.org community to connect with other families managing Lennox-Gastaut syndrome for peer support and resource sharing.


• Explore clinical trials via ClinicalTrials.gov to see if your loved one may be a candidate for emerging therapies.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Lennox-Gastaut Syndrome.


• Orphanet: Rare Disease Database (ORPHA: 504).


• OMIM (Online Mendelian Inheritance in Man): Lennox-Gastaut Syndrome (#605681).


• LGS Foundation: Comprehensive resources for patients and families.